• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯二氮䓬类肽模拟物:动物细胞中Ras法尼基化的强效抑制剂。

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells.

作者信息

James G L, Goldstein J L, Brown M S, Rawson T E, Somers T C, McDowell R S, Crowley C W, Lucas B K, Levinson A D, Marsters J C

机构信息

Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas 75235.

出版信息

Science. 1993 Jun 25;260(5116):1937-42. doi: 10.1126/science.8316834.

DOI:10.1126/science.8316834
PMID:8316834
Abstract

Oncogenic Ras proteins transform animal cells to a malignant phenotype only when modified by farnesyl residues attached to cysteines near their carboxyl termini. The farnesyltransferase that catalyzes this reaction recognizes tetrapeptides of the sequence CAAX, where C is cysteine, A is an aliphatic amino acid, and X is a carboxyl-terminal methionine or serine. Replacement of the two aliphatic residues with a benzodiazepine-based mimic of a peptide turn generated potent inhibitors of farnesyltransferase [50 percent inhibitory concentration (IC50) < 1 nM]. Unlike tetrapeptides, the benzodiazepine peptidomimetics enter cells and block attachment of farnesyl to Ras, nuclear lamins, and several other proteins. At micromolar concentrations, these inhibitors restored a normal growth pattern to Ras-transformed cells. The benzodiazepine peptidomimetics may be useful in the design of treatments for tumors in which oncogenic Ras proteins contribute to abnormal growth, such as that of the colon, lung, and pancreas.

摘要

致癌性Ras蛋白只有在其羧基末端附近的半胱氨酸被法尼基残基修饰时,才会将动物细胞转化为恶性表型。催化此反应的法尼基转移酶识别序列为CAAX的四肽,其中C为半胱氨酸,A为脂肪族氨基酸,X为羧基末端的甲硫氨酸或丝氨酸。用基于苯并二氮杂䓬的肽转角模拟物取代两个脂肪族残基,可产生强效的法尼基转移酶抑制剂[半数抑制浓度(IC50)<1 nM]。与四肽不同,苯并二氮杂䓬肽模拟物可进入细胞,并阻断法尼基与Ras、核纤层蛋白及其他几种蛋白质的结合。在微摩尔浓度下,这些抑制剂可使Ras转化细胞恢复正常生长模式。苯并二氮杂䓬肽模拟物可能有助于设计针对致癌性Ras蛋白导致异常生长的肿瘤(如结肠癌、肺癌和胰腺癌)的治疗方法。

相似文献

1
Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells.苯二氮䓬类肽模拟物:动物细胞中Ras法尼基化的强效抑制剂。
Science. 1993 Jun 25;260(5116):1937-42. doi: 10.1126/science.8316834.
2
Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor.法尼基转移酶抑制剂对ras依赖性转化的选择性抑制作用。
Science. 1993 Jun 25;260(5116):1934-7. doi: 10.1126/science.8316833.
3
Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.法尼基转移酶的双底物抑制剂:一类新型的Ras转化细胞特异性抑制剂。
Oncogene. 1995 May 4;10(9):1763-79.
4
Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro.K-RasB的聚赖氨酸和CVIM序列决定了异戊二烯化的特异性,并在体外赋予对苯二氮卓类拟肽的抗性。
J Biol Chem. 1995 Mar 17;270(11):6221-6. doi: 10.1074/jbc.270.11.6221.
5
Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity.具有细胞活性和体内活性的高效Ras法尼基转移酶抑制剂的研发。
J Med Chem. 1996 Jan 5;39(1):224-36. doi: 10.1021/jm950642a.
6
Novel anticancer agents move closer to reality.
Science. 1993 Jun 25;260(5116):1877-8. doi: 10.1126/science.8316828.
7
Resistance of K-RasBV12 proteins to farnesyltransferase inhibitors in Rat1 cells.大鼠1细胞中K-RasBV12蛋白对法尼基转移酶抑制剂的抗性。
Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4454-8. doi: 10.1073/pnas.93.9.4454.
8
Farnesyl protein transferase inhibitors as potential cancer chemopreventives.法尼基蛋白转移酶抑制剂作为潜在的癌症化学预防剂。
Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):267-82.
9
Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug design.抑制Ras异戊二烯化:新型抗癌药物设计的信号靶点。
Anticancer Drug Des. 1997 Jun;12(4):229-38.
10
Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.法尼基转移酶抑制剂可阻断I型神经纤维瘤病(NF1)的恶性表型。
Cancer Res. 1995 Aug 15;55(16):3569-75.

引用本文的文献

1
Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?介导Ras突变型癌症中的激酶活性:个体化治疗方法的潜力?
Front Pharmacol. 2024 Sep 20;15:1441938. doi: 10.3389/fphar.2024.1441938. eCollection 2024.
2
Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.深入了解翻译后修饰及其在塑造肿瘤微环境中的新兴作用。
Signal Transduct Target Ther. 2021 Dec 20;6(1):422. doi: 10.1038/s41392-021-00825-8.
3
Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell Carcinomas.
法尼基转移酶抑制剂在鳞状细胞癌联合治疗方案中的潜力
Cancers (Basel). 2021 Oct 22;13(21):5310. doi: 10.3390/cancers13215310.
4
Ras Signaling in Breast Cancer.乳腺癌中的Ras信号传导
Adv Exp Med Biol. 2021;1187:81-101. doi: 10.1007/978-981-32-9620-6_4.
5
Small molecule inhibitors of RAS proteins with oncogenic mutations.具有致癌突变的 RAS 蛋白的小分子抑制剂。
Cancer Metastasis Rev. 2020 Dec;39(4):1107-1126. doi: 10.1007/s10555-020-09911-9.
6
Biology, pathology, and therapeutic targeting of RAS.RAS 的生物学、病理学和治疗靶点。
Adv Cancer Res. 2020;148:69-146. doi: 10.1016/bs.acr.2020.05.002. Epub 2020 Jul 9.
7
Farnesyltransferase-Mediated Delivery of a Covalent Inhibitor Overcomes Alternative Prenylation to Mislocalize K-Ras.法尼基转移酶介导的共价抑制剂递送克服了K-Ras错误定位的替代异戊二烯化作用。
ACS Chem Biol. 2017 Jul 21;12(7):1956-1962. doi: 10.1021/acschembio.7b00374. Epub 2017 Jun 19.
8
Microwave-Assisted Syntheses of Bioactive Seven-Membered, Macro-Sized Heterocycles and Their Fused Derivatives.微波辅助合成生物活性七元大环杂环及其稠合衍生物
Molecules. 2016 Aug 9;21(8):1032. doi: 10.3390/molecules21081032.
9
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design.直接靶向 KRAS 的小分子抑制剂:从结构见解到基于机制的设计。
Nat Rev Drug Discov. 2016 Nov;15(11):771-785. doi: 10.1038/nrd.2016.139. Epub 2016 Jul 29.
10
Pharmacological Inhibition of Protein Lipidation.蛋白质脂化的药理学抑制作用。
J Membr Biol. 2015 Dec;248(6):929-41. doi: 10.1007/s00232-015-9835-4. Epub 2015 Aug 18.